Trials / Enrolling By Invitation
Enrolling By InvitationNCT07203638
Efficacy and Safety of Prophylactic Antibiotics in Preventing Ventilator-associated Pneumonia: A Randomized, Double Blind, Placebo-controlled Trial
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Esraa Salah Mohamed Abdallah Eladl · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate efficacy and safety of prophylactic antibiotics in preventing early ventilator-associated pneumonia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Beta Lactam Antibiotics | Beta lactam cefipim infusion (20mg/kg -12h -2 days ) total volume 10 ml |
| DRUG | Salin | Patient will receive .9 % saline (10ml /12h/2days) |
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2025-11-01
- Completion
- 2025-11-01
- First posted
- 2025-10-02
- Last updated
- 2025-10-02
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07203638. Inclusion in this directory is not an endorsement.